These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 25250996)

  • 21. Spotlight on retapamulin in impetigo and other uncomplicated superficial skin infections.
    Yang LP; Keam SJ
    Am J Clin Dermatol; 2008; 9(6):411-3. PubMed ID: 18973410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacterial diseases of the skin.
    Edlich RF; Winters KL; Britt LD; Long WB
    J Long Term Eff Med Implants; 2005; 15(5):499-510. PubMed ID: 16218899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retapamulin: a semisynthetic pleuromutilin compound for topical treatment of skin infections in adults and children.
    Jacobs MR
    Future Microbiol; 2007 Dec; 2(6):591-600. PubMed ID: 18041900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Skin and soft tissue infection.
    Sharma S; Verma KK
    Indian J Pediatr; 2001 Jul; 68 Suppl 3():S46-50. PubMed ID: 11980459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interventions for impetigo.
    Koning S; Verhagen AP; van Suijlekom-Smit LW; Morris A; Butler CC; van der Wouden JC
    Cochrane Database Syst Rev; 2004; (2):CD003261. PubMed ID: 15106198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topical retapamulin ointment, 1%, versus sodium fusidate ointment, 2%, for impetigo: a randomized, observer-blinded, noninferiority study.
    Oranje AP; Chosidow O; Sacchidanand S; Todd G; Singh K; Scangarella N; Shawar R; Twynholm M;
    Dermatology; 2007; 215(4):331-40. PubMed ID: 17911992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impetigo: an overview.
    Darmstadt GL; Lane AT
    Pediatr Dermatol; 1994 Dec; 11(4):293-303. PubMed ID: 7899177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current options for the treatment of impetigo in children.
    Sladden MJ; Johnston GA
    Expert Opin Pharmacother; 2005 Oct; 6(13):2245-56. PubMed ID: 16218885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retapamulin: an antibacterial with a novel mode of action in an age of emerging resistance to Staphylococcus aureus.
    Weinberg JM; Tyring SK
    J Drugs Dermatol; 2010 Oct; 9(10):1198-204. PubMed ID: 20941943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of a new cream formulation of mupirocin: comparison with oral and topical agents in experimental skin infections.
    Gisby J; Bryant J
    Antimicrob Agents Chemother; 2000 Feb; 44(2):255-60. PubMed ID: 10639346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Where to from here? The treatment of impetigo in children as resistance to fusidic acid emerges.
    Vogel A; Lennon D; Best E; Leversha A
    N Z Med J; 2016 Oct; 129(1443):77-83. PubMed ID: 27736855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparative review of current topical antibiotics for impetigo.
    Galindo E; Hebert AA
    Expert Opin Drug Saf; 2021 Jun; 20(6):677-683. PubMed ID: 33726585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antibiotic susceptibility of Staphylococcus aureus strains responsible for community-acquired skin infections].
    Bernard P; Jarlier V; Santerre-Henriksen A
    Ann Dermatol Venereol; 2008 Jan; 135(1):13-9. PubMed ID: 18342068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disseminated bullous impetigo and atopic dermatitis: Case series and literature review.
    Mannschreck D; Feig J; Selph J; Cohen B
    Pediatr Dermatol; 2020 Jan; 37(1):103-108. PubMed ID: 31755570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutaneous community-acquired methicillin-resistant Staphylococcus aureus infection in participants of athletic activities.
    Cohen PR
    South Med J; 2005 Jun; 98(6):596-602. PubMed ID: 16004165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiogram testing of pediatric skin infections in the era of methicillin-resistant Staphylococci aureus: an Egyptian University Hospital-based study.
    Abdel Fattah NS; Darwish YW
    Int J Dermatol; 2012 Dec; 51(12):1441-7. PubMed ID: 22928620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impetigo: incidence and treatment in Dutch general practice in 1987 and 2001--results from two national surveys.
    Koning S; Mohammedamin RS; van der Wouden JC; van Suijlekom-Smit LW; Schellevis FG; Thomas S
    Br J Dermatol; 2006 Feb; 154(2):239-43. PubMed ID: 16433791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of primary care prescribers in the diagnosis and management of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
    Lawrence KR; Golik MV; Davidson L
    Am J Ther; 2009; 16(4):333-8. PubMed ID: 19617720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impetigo in epidemic and nonepidemic phases: an incidence study over 4(1/2) years in a general population.
    Rørtveit S; Rortveit G
    Br J Dermatol; 2007 Jul; 157(1):100-5. PubMed ID: 17553056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Non bullous impetigo: streptococcal or staphylococcal?].
    Henno A; de la Brassinne M
    Rev Med Liege; 2004 Sep; 59(9):517-21. PubMed ID: 15559440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.